The ABRIZYL brand, founded in 2004 (Switzerland), from 2951 sister brands and 17477 competing brands. ABRIZYL is a brand of NOVARTIS N, listed on the stock exchange of Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. ABRIZYL belongs to the Drug Manufacturers business sector.